Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,923 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients Aged 85 Years Old or Older Is Associated with a Good Prognosis Compared to Conservative Treatment without Any Invasive Procedure.
Yamada S, Dohi O, Harusato A, Iwai N, Horie R, Yasuda T, Yamada N, Horii Y, Majima A, Zen K, Kimura H, Yagi N, Naito Y, Itoh Y. Yamada S, et al. Among authors: kimura h. Digestion. 2022;103(5):386-396. doi: 10.1159/000525422. Epub 2022 Jul 21. Digestion. 2022. PMID: 35863326
Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma.
Jo M, Yasui K, Kirishima T, Shima T, Niimi T, Katayama T, Mori T, Funaki J, Sumida Y, Fujii H, Takami S, Kimura H, Mitsumoto Y, Minami M, Yamaguchi K, Yoshinami N, Mizuno M, Sendo R, Tanaka S, Shintani H, Kagawa K, Okanoue T, Itoh Y. Jo M, et al. Among authors: kimura h. Hepatol Res. 2014 Dec;44(13):1329-38. doi: 10.1111/hepr.12308. Epub 2014 Apr 2. Hepatol Res. 2014. PMID: 24528772
[Outcomes of treatment with gemcitabine for unresectable pancreatic cancer].
Nobutani K, Kutsumi H, Funatsu E, Nishida K, Ikezawa S, Shiomi H, Fukiya E, Suzuki T, Masuda K, Hata K, Nakamura H, Okuyama Y, Kimura H, Yagi N, Sugeta N, Yashiro H, Otsuka H, Suyama Y, Fujimoto S. Nobutani K, et al. Among authors: kimura h. Gan To Kagaku Ryoho. 2004 Feb;31(2):199-203. Gan To Kagaku Ryoho. 2004. PMID: 14997751 Japanese.
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma.
Takahashi A, Moriguchi M, Seko Y, Ishikawa H, Yo T, Kimura H, Fujii H, Shima T, Mitsumoto Y, Ishiba H, Takashima H, Nagao Y, Jo M, Arai M, Hara T, Okajima A, Muramatsu A, Morita A, Yoshinami N, Nakajima T, Mitsuyoshi H, Umemura A, Nishikawa T, Yamaguchi K, Itoh Y. Takahashi A, et al. Among authors: kimura h. Anticancer Res. 2019 Sep;39(9):5149-5156. doi: 10.21873/anticanres.13710. Anticancer Res. 2019. PMID: 31519627
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study.
Fujii H, Doi H, Ko T, Fukuma T, Kadono T, Asaeda K, Kobayashi R, Nakano T, Doi T, Nakatsugawa Y, Yamada S, Nishimura T, Tomatsuri N, Sato H, Okuyama Y, Kimura H, Kishimoto E, Nakabe N, Shima T. Fujii H, et al. Among authors: kimura h. BMC Gastroenterol. 2020 Jul 10;20(1):217. doi: 10.1186/s12876-020-01369-x. BMC Gastroenterol. 2020. PMID: 32650722 Free PMC article.
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis.
Takahashi A, Moriguchi M, Seko Y, Shima T, Mitsumoto Y, Takashima H, Kimura H, Fujii H, Ishikawa H, Takaharu Y, Ishiba H, Morita A, Jo M, Nagao Y, Arai M, Hara T, Okajima A, Muramatsu A, Yoshinami N, Nakajima T, Mitsuyoshi H, Umemura A, Nishikawa T, Yamaguchi K, Okanoue T, Itoh Y. Takahashi A, et al. Among authors: kimura h. Cancers (Basel). 2020 Mar 23;12(3):754. doi: 10.3390/cancers12030754. Cancers (Basel). 2020. PMID: 32209994 Free PMC article.
5,923 results